Investor Ideas Adds New
Canadian #Stocks in #Mining; (#TSX: $CAT.V), (#CSE: $USGD.C, $GGC.C) &
#Biotech (TSX: $BCT.V)
Point Roberts, WA, Delta BC – March 9, 2018 –
Investorideas.com, a global news source and leading investor resource covering
actively traded sectors announces this week’s additions to its global stock
directories in mining and biotech.
Investorideas.com tracks companies in high-profile
trading sectors and makes ongoing additions to its stock directories for its members. Free previews of all
directories are available to the public with full login access only accessible
to members.
All new mining companies are listed on Canadian
Exchanges and are involved in gold or mineral exploration in both Canada and
the United States.
The latest biotech company is both TSX and OTCQB
listed and is involved in immuno-oncology for the management of cancer.
New Mining Companies Added:
American Pacific
Mining Corp. (CSE:USGD) is a new gold
explorer focused on precious metal opportunities in the Western United States.
Tuscarora is a high grade, early stage gold project located in a prime precious
metal district in Nevada, only 35km northeast of the Carlin trend, 20km
southwest of the Jerritt Canyon deposit, and 50km east-northeast of the Midas
deposit. American Pacific is Eyeing a Gold Discovery amidst gold’s next bull
market.
Chimata Gold Corp. (TSX: CAT.V) engages in the
acquisition and exploration of mineral properties in Canada. It has an option
to earn up to 100% interest in mineral concessions located about 12 kilometers
from Squamish, British Columbia.
Generic
Gold Corp. (CSE:GGC) is a Canadian exploration company focused on gold
projects in the Tintina Gold Belt of the Yukon Territory of Canada. Generic's
board of directors and management team is led by experienced mining industry
professionals, with expertise in exploration, finance, capital markets, and
mine development.
New Biotech Companies:
BriaCell
Therapeutics Corp. (TSX:BCT.V; OTCQB:BCTXF) is an immuno-oncology focused biotechnology
company developing a targeted and safe approach to the management of cancer.
Bria-IMT™ (SV-BR-1-GM), the Company's lead product candidate, is derived from a
specific breast cancer cell line. It is genetically engineered to release granulocyte-macrophage
colony-stimulating factor (GM-CSF), a substance that activates the immune
system. We believe that Bria-IMT™ helps the body to recognize and kill tumor
cells by activating T cells that attack the tumor and B cells that produce
anti-tumor antibodies. BriaCell is also developing Bria-OTS™, an off-the-shelf
personalized Immunotherapy. Bria-OTS™ consists of 14 individually
pre-manufactured genetic alleles. BriaCell’s BriaDX™ companion diagnostic
reveals a patient’s specific HLA-types and the 2 best matching alleles are
administered to the patient. BriaCell’s 14 alleles (8 Class I and 6 Class II)
cover approximately 90% of the Breast Cancer population while eliminating the
complex manufacturing logistics required for other personalized immunotherapies.
Bria-OTS™ is a personalized therapy without the need for personalized
manufacturing. Yet another item in the BriaCell pipeline is a novel, selective
protein kinase C delta (PKCĪ“) inhibitor. PKCĪ“ inhibitors have shown activity in
a number of pre-clinical models of RAS genes’ transformed cancers including
breast, pancreatic, non-small cell lung cancer and neuroendocrine tumors (such
as carcinoid tumors).
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Ideas
www.Investorideas.com is a meeting place for global investors, featuring news, stock
directories, video, podcasts,
company profiles, interviews and more in leading sectors. Sectors we cover
include tech (AI, drones, internet of things) , payments, crypto and
blockchain, biotech, mining, energy, renewable energy, water , marijuana and
hemp stocks, food and beverage, defense and security (biometrics/cyber) ,Latin
America, sports, entertainment, luxury brands and gaming.
The Investorideas.com content portfolio goes beyond
the www.investorideas.com site to include 14 blogs on Blogger.com, 7
Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com,
all featuring Investorideas.com news and content.
Investor Ideas Stock Directories for global investors:
From water stocks to gold and mining stocks,
renewable energy, nanotech, defense, technology, biotech and more – use our
stock directories and access them online 24/7 with login as a member to find
your next big idea!
Investorideas.com is also a CSE service provider: http://thecse.com/en/services/services-for-listed-companies
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Contact each company directly regarding content and
press release questions. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment